Class III · Low risk
Glimepiride Tablets
Misprint on tablet
Is Glimepiride recalled?
Yes — there is an active recall. 6 ongoing FDA recalls mention Glimepiride (21 total). Check the affected lots below.
Most common reason: cGMP deviation (15 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Glimepiride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Glimepiride recalls on record
none so far in 2026; 21 on record, newest first
Class III · Low risk
Glimepiride Tablets
Misprint on tablet
Class II · Moderate risk
Glimepiride USP
CGMP deviations.
Class II · Moderate risk
Glimepiride Tablets USP
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Glimepiride Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Glimepiride 2 mg tablets
cGMP Deviations
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations
Class II · Moderate risk
Glimepiride Tablets
CGMP Deviations
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Glimepiride
cGMP deviations
Class II · Moderate risk
Glimepiride Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Glimepiride Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Pioglitazone and Glimepiride Tablets
Failed Dissolution Specifications
Class II · Moderate risk
Glimepiride Tablets
Failed Stability Specifications: Micro Labs is recalling two lots due to out of specification results during stability testing.
Class II · Moderate risk
GLIMEPIRIDE Tablet
Labeling:Label Mixup; GLIMEPIRIDE, Tablet, 1 mg may be potentially mislabeled as clomiPRAMINE HCl, Capsule, 50 mg, NDC 51672401205, Pedigree: AD73525_4, EXP: 5/30/2014.
Class II · Moderate risk
Glimepiride Tablets USP
Failed Tablet/Capsule Specifications: One oversized tablet was found in a sealed 100 count bottle of Glimepiride at the retail level.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.